Key Highlights
- Shares plummeted approximately 5.4% Monday, establishing a fresh 52-week low at $14.62
- CEO Sean Connolly departing May 31 after decade-long tenure; John Brase assumes control June 1
- Third quarter earnings per share of $0.39 fell short of the $0.40 Wall Street consensus
- Wall Street firms slash price objectives; average target now $16.07 with “Reduce” consensus
- Current dividend yield approaches 9.8%, though negative payout ratio threatens long-term sustainability
Conagra Brands experienced another difficult trading session Monday, with shares tumbling approximately 5.4% and establishing a fresh 52-week low at $14.62. Trading volume surged, reaching nearly 2 million shares.
The sharp decline followed a major leadership announcement. CEO Sean Connolly, who has led the food manufacturer for ten years, will depart his position on May 31. The board has appointed John Brase as his successor, with the transition taking effect June 1.
Brase brings extensive industry experience to the role. His background includes serving as Chief Operating Officer at J.M. Smucker and holding executive positions at Procter & Gamble. Conagra confirmed he will simultaneously join the company’s board.
Wall Street Responds with Caution
BofA Securities maintained its Underperform stance and $15 price objective on CAG shares following the leadership announcement. Analysts characterized the timing as unexpected and identified multiple challenges awaiting the new chief executive.
Primary among these concerns: inflationary headwinds that impacted fiscal 2026 earnings per share and threaten fiscal 2027 performance. BofA highlighted the dividend payout ratio, currently exceeding 80% — substantially above the company’s stated 50–55% target corridor.
The company’s net debt to EBITDA ratio currently stands at 3.8x. BofA suggested potential brand divestitures to improve the balance sheet, specifically mentioning Hebrew National and Odom’s Tennessee Pride as assets previously discussed for sale.
Deutsche Bank reduced its price objective to $14 while maintaining a Hold recommendation. JPMorgan and Stifel both adjusted their targets downward to $17. UBS lowered its forecast to $16 from $20, citing ongoing margin compression and mounting fiscal 2027 concerns.
Wall Street’s current consensus stands at “Reduce” — comprising 1 Buy, 12 Hold, and 4 Sell ratings — with a mean price target of $16.07.
Disappointing Quarterly Performance Compounds Pressure
Conagra released third quarter financial results on April 1. Earnings per share of $0.39 missed the Street’s $0.40 expectation. While revenue of $2.79 billion exceeded the $2.76 billion estimate, total quarterly sales declined 1.9% versus the prior year period.
The same quarter last year delivered $0.51 in EPS — representing a significant decline. Net margin currently sits in negative territory at -0.39%, with the price-to-earnings ratio registering at -142.54.
Organic sales advanced 2.4% during the quarter, supported by a 0.5% volume uptick and a 1.9% favorable impact from pricing and product mix. However, margins underperformed expectations, while a reduced equity contribution from Ardent Mills pressured profitability.
Management tightened its fiscal 2026 outlook following the quarterly report. Wall Street currently projects full-year earnings per share of $2.35.
CAG’s 50-day moving average stands at $17.52, with the 200-day moving average at $17.60 — current trading levels sit significantly beneath both technical indicators. Shares have declined roughly 37% over the trailing twelve months and are off approximately 10.6% year-to-date.
The quarterly dividend of $0.35 per share has a June 3 payment date, with April 30 established as the record date. Based on current pricing, this represents an annualized yield of approximately 9.8%.
